B.R.A.I.N. Biotechnology Research And Information Network AG (DE000520) | WebDisclosure

Basculer en Français

8201	Companies
109005	Keywords
51275	Articles
60079	Press releases

Headlines Articles Press releases B.R.A.I.N. Biotechnology Research And Information Network AG

Home
Companies
B.R.A.I.N. Biotechnology Research And Information Network AG

BRIEF

published on 10/31/2024 at 19:25, 2 days 17 hours ago

Un accord de licence exclusif renforce les activités pharmaceutiques de BRAIN Biotech

CERVEAU Biotechnologie Technologie CRISPR-Cas G-dase E® Licences Pharmaceutiques Akribion Thérapeutique
BRIEF

published on 10/31/2024 at 19:25, 2 days 17 hours ago

Exclusive Licensing Agreement Boosts BRAIN Biotech's Pharma Ventures

BRAIN Biotech CRISPR-Cas Technology G-dase E® Pharma Licensing Akribion Therapeutics
PRESS RELEASE

published on 10/31/2024 at 19:20, 2 days 17 hours ago

BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E(R) CRISPR-Cas technology, offering up to EUR 92.3 million R&D and commercial milestone fees along with royalties

BRAIN Biotech AG CRISPR-Cas Technology Pharma Licensing Agreement Akribion Therapeutics GmbH G-dase E(R)
BRIEF

published on 10/31/2024 at 19:16, 2 days 18 hours ago

BRAIN Biotech AG conclut un accord de licence avec Akribion Therapeutics

Redevance Licences Biotechnologiques Technologie CRISPR-Cas Accord Pharmaceutique Frais D'étape
BRIEF

published on 10/31/2024 at 19:16, 2 days 18 hours ago

BRAIN Biotech AG Secures Licensing Deal with Akribion Therapeutics

Royalties Biotech Licensing CRISPR-Cas Technology Pharma Agreement Milestone Fees
PRESS RELEASE

published on 10/31/2024 at 19:11, 2 days 18 hours ago

EQS-Adhoc: BRAIN Biotech AG signs exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology with Akribion Therapeutics GmbH for up to EUR 92.3 million milestone fees plus royalties
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E® CRISPR-Cas technology, potentially receiving up to EUR 92.3 million milestone fees and royalties

BRAIN Biotech AG CRISPR-Cas Technology Pharma Licensing Agreement Akribion Therapeutics GmbH G-dase E®
BRIEF

published on 10/03/2024 at 14:05, 30 days 23 hours ago

Prof. Dr. Wiltrud Treffenfeldt Steps Down from BRAIN Biotech AG Supervisory Board

Biotechnology Resignation Supervisory Board BRAIN Biotech AG Wiltrud Treffenfeldt
BRIEF

published on 10/03/2024 at 14:05, 30 days 23 hours ago

Le professeur Wiltrud Treffenfeldt quitte le conseil de surveillance de BRAIN Biotech AG

Biotechnologie Démission Conseil De Surveillance BRAIN Biotech SA Wiltrud Treffenfeldt
PRESS RELEASE

published on 10/03/2024 at 14:00, 30 days 23 hours ago

Prof. Dr. Wiltrud Treffenfeldt leaves Supervisory Board of BRAIN Biotech AG for personal reasons
Prof. Dr. Wiltrud Treffenfeldt resigns from Supervisory Board of BRAIN Biotech AG for personal reasons. Search for successor initiated. Company specializes in industrial biotechnology solutions

Biotechnology Resignation Supervisory Board Successor BRAIN Biotech AG
BRIEF

published on 09/20/2024 at 19:55, 1 month 12 days ago

BRAIN Biotech AG Secures EUR 128.88 Million Deal with Royalty Pharma

Non-dilutive Financing BRAIN Biotech AG Royalty Monetization Investigational Compound Industrial Enzymes

1 2 ... 7

Accesswire

Published on 11/03/2024 at 00:45, 12 hours 31 minutes ago

Holtway Global Hedge Expands into Europe, Providing Exclusive Pre-IPO and IPO Access to Companies Led by Visionary Founders like Elon Musk and Sam Altman
Published on 11/02/2024 at 19:15, 18 hours 1 minute ago

Hank Payments Announces Closing of Financing and Settlements
Published on 11/02/2024 at 16:10, 21 hours 6 minutes ago

Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
Published on 11/02/2024 at 14:30, 22 hours 46 minutes ago

Spa Sciences Health Introduces Revolutionary Nasal Irrigation System at CVS
Published on 11/02/2024 at 00:48, 1 day 12 hours ago

OneSoft Solutions Inc. Announces the Completion of Its Acquisition by Irth Solutions LLC, a Blackstone Portfolio Company

View all ACCESSWIRE

EQS Group

Published on 11/01/2024 at 21:31, 1 day 15 hours ago

Original-Research: Telefonica Deutschland Holding AG (von First Berlin Equity Research GmbH): Buy
Published on 11/01/2024 at 18:18, 1 day 18 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/01/2024 at 17:47, 1 day 19 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/01/2024 at 17:10, 1 day 20 hours ago

EQS-Adhoc: fox e-mobility AG: provisional debt restructuring moratorium of Fox Automotive Switzerland AG
Published on 11/01/2024 at 16:00, 1 day 21 hours ago

Total Voting Rights

Les Echos

Published on 10/31/2024 at 20:26, 2 days 16 hours ago

I.CERAM - Résultat du 1er semestre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Déclaration hebdomadaire d'opérations effectuées du 28 au 31 octobre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Disclosure of transactions in own shares on October 28 to October 31, 2024
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2024 : +3%
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION: THIRD QUARTER 2024 TURNOVER UP 3%

View all LES ECHOS COMFI WIRE